Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Cervical Cancer

Free Subscription Articles published in BMC Cancer Retrieve available abstracts of 197 articles: HTML format

Single Articles

April 2024
1. GU Z, Yang C, Zhang K, Wu H, et al
   Development and validation of a nomogram for predicting sever cancer-related fatigue in patients with cervical cancer.
   BMC Cancer. 2024;24:492.
   PubMed     Abstract available
   
   
   
2. NAKISIGE C, de Fouw M, Nakalembe M, Orem J, et al
   Baseline knowledge on risk factors, symptoms and intended behavior of women and men towards screening and treatment of cervical cancer in rural Uganda: a cross-sectional study.
   BMC Cancer. 2024;24:450.
   PubMed     Abstract available
   
   
   
3. LI Z, Zhou G, Jiang L, Wang M, et al
   Analysis of related factors for pathological upgrading of cervical biopsy from CIN3 to cancer after conical resection.
   BMC Cancer. 2024;24:401.
   PubMed     Abstract available
   
   
   March 2024
4. LI X, Zhao Y, Xiang F, Zhang X, et al
   Evaluation of the diagnostic performance of colposcopy in the detection of cervical high-grade squamous intraepithelial lesions among women with transformation zone type 3.
   BMC Cancer. 2024;24:381.
   PubMed     Abstract available
   
   
   
5. NAKIGOZI H, Ategyeka PM, Nabadda S, Ndejjo R, et al
   Positivity rates, trends and experiences of health workers on human papillomavirus screened using genexpert in Uganda: a three-year retrospective cohort study.
   BMC Cancer. 2024;24:375.
   PubMed     Abstract available
   
   
   
6. CUI X, Wang H, Chen M, Seery S, et al
   Assessing colposcopy competencies in medically underserved communities: a multi-center study in China.
   BMC Cancer. 2024;24:349.
   PubMed     Abstract available
   
   
   
7. GHASEMI M, Savabi-Esfahani M, Noroozi M, Satari M, et al
   Prediction of cervical cancer screening: application of the information-motivation-behavioral skills model.
   BMC Cancer. 2024;24:351.
   PubMed     Abstract available
   
   
   
8. KHANNA D, Sharma P, Budukh A, Vishwakarma R, et al
   Rural-urban disparity in cancer burden and care: findings from an Indian cancer registry.
   BMC Cancer. 2024;24:308.
   PubMed     Abstract available
   
   
   
9. ZHANG Y, Liu S, Chen M, Ou Q, et al
   Preimmunization with Listeria-vectored cervical cancer vaccine candidate strains can establish specific T-cell immune memory and prevent tumorigenesis.
   BMC Cancer. 2024;24:288.
   PubMed     Abstract available
   
   
   February 2024
10. BONLOKKE S, Blaakaer J, Steiniche T, Iachina M, et al
    Social factors and age play a significant role in cervical cancer and advanced-stage disease among Danish women.
    BMC Cancer. 2024;24:259.
    PubMed     Abstract available
    
    
    
11. NAKIGOZI H, Ndejjo R, Bazeyo W, Nabaggala A, et al
    Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
    BMC Cancer. 2024;24:243.
    PubMed     Abstract available
    
    
    
12. CORREDOR C, Pineros M, Wiesner C, de Vries E, et al
    Using administrative registries as a source for population-based cancer incidence and mortality.
    BMC Cancer. 2024;24:232.
    PubMed    
    
    
    
13. ZHONG ML, Liu YC, Yang JT, Wang YN, et al
    Treatment for locally resectable stage IIIC1r cervical cancer: surgery or chemoradiotherapy?
    BMC Cancer. 2024;24:217.
    PubMed     Abstract available
    
    
    
14. XIAO L, Dong X, Sun J, Zhang X, et al
    Focused ultrasound versus the loop electrosurgical excision procedure to treat women with cervical high-grade squamous intraepithelial lesions under 40: a retrospective study.
    BMC Cancer. 2024;24:169.
    PubMed     Abstract available
    
    
    
15. CETINA-PEREZ L, Luvian-Morales J, Delgadillo-Gonzalez M, Castro-Eguiluz D, et al
    Sociodemographic characteristics and their association with survival in women with cervical cancer.
    BMC Cancer. 2024;24:161.
    PubMed     Abstract available
    
    
    January 2024
16. LIU H, Cui Y, Chang C, Zhou Z, et al
    Development and validation of a (18)F-FDG PET/CT radiomics nomogram for predicting progression free survival in locally advanced cervical cancer: a retrospective multicenter study.
    BMC Cancer. 2024;24:150.
    PubMed     Abstract available
    
    
    
17. PAN XB, Lu Y, Wei YS, Yao DS, et al
    Efficacy of treatment patterns based on concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma.
    BMC Cancer. 2024;24:106.
    PubMed     Abstract available
    
    
    
18. YU JH, Tong CJ, Huang QD, Ye YL, et al
    Long-term outcomes of pelvic exenterations for gynecological malignancies: a single-center retrospective cohort study.
    BMC Cancer. 2024;24:88.
    PubMed     Abstract available
    
    
    
19. KAIZILEGE GK, Ndaboine E, Chuma C, Mujuni F, et al
    Unraveling cervical cancer screening dilemmas: histopathological insights from VIA and LEEP at bugando medical centre, Mwanza.
    BMC Cancer. 2024;24:66.
    PubMed     Abstract available
    
    
    
20. KUSSIA B, Shewangizaw M, Abebe S, Alemu H, et al
    Health care seeking behaviour towards cervical cancer screening among women aged 30-49 years in Arbaminch town, Southern Ethiopia, 2023.
    BMC Cancer. 2024;24:38.
    PubMed     Abstract available
    
    
    December 2023
21. ZEWDIE A, Shitu S, Kebede N, Gashaw A, et al
    Determinants of late-stage cervical cancer presentation in Ethiopia: a systematic review and meta-analysis.
    BMC Cancer. 2023;23:1228.
    PubMed     Abstract available
    
    
    
22. VIGNESHWARAN E, Goruntla N, Bommireddy BR, Mantargi MJS, et al
    Prevalence and predictors of cervical cancer screening among HIV-positive women in rural western Uganda: insights from the health-belief model.
    BMC Cancer. 2023;23:1216.
    PubMed     Abstract available
    
    
    
23. KONG L, Xiao X, Xu T, Wan R, et al
    Immediate histologic correlation in patients with different HPV genotypes and ages: a single center analysis in China.
    BMC Cancer. 2023;23:1211.
    PubMed     Abstract available
    
    
    November 2023
24. CHENG Z, Wang H, Yang Z, Li J, et al
    LMP2 and TAP2 impair tumor growth and metastasis by inhibiting Wnt/beta-catenin signaling pathway and EMT in cervical cancer.
    BMC Cancer. 2023;23:1128.
    PubMed     Abstract available
    
    
    
25. ZHANG H, Yang Y, Xing W, Li Y, et al
    Expression and gene regulatory network of S100A16 protein in cervical cancer cells based on data mining.
    BMC Cancer. 2023;23:1124.
    PubMed     Abstract available
    
    
    
26. GLINSKA P, Komerska K, Janik B, Olkowicz J, et al
    HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.
    BMC Cancer. 2023;23:1118.
    PubMed     Abstract available
    
    
    
27. MWALIKO E, Itsura P, Keter A, De Bacquer D, et al
    Survival of cervical cancer patients at Moi teaching and Referral Hospital, Eldoret in western Kenya.
    BMC Cancer. 2023;23:1104.
    PubMed     Abstract available
    
    
    
28. BUKOWSKI A, Hoyo C, Vielot NA, Graff M, et al
    Epigenome-wide methylation and progression to high-grade cervical intraepithelial neoplasia (CIN2+): a prospective cohort study in the United States.
    BMC Cancer. 2023;23:1072.
    PubMed     Abstract available
    
    
    
29. LI X, Wei X, Liu X, Wang N, et al
    The analysis of HPV integration sites based on nanopore sequencing and the profiling changes along the course of photodynamic therapy.
    BMC Cancer. 2023;23:1052.
    PubMed     Abstract available
    
    
    October 2023
30. TSEGAYE K, Hagos A, Kindie H, Minyihun A, et al
    Evaluation of cervical cancer screening program in Gondar city administration public health facilities, Northwest Ethiopia, 2021: mixed method approach.
    BMC Cancer. 2023;23:1034.
    PubMed     Abstract available
    
    
    
31. LV N, Zhao Y, Song Y, Ji M, et al
    Development of a sensitive droplet digital PCR according to the HPV infection specificity in Chinese population.
    BMC Cancer. 2023;23:1022.
    PubMed     Abstract available
    
    
    
32. ZAFAR S, Khan K, Badshah Y, Shahid K, et al
    Correction: Exploring the prognostic significance of PKCepsilon variants in cervical cancer.
    BMC Cancer. 2023;23:963.
    PubMed    
    
    
    
33. MISGUN T, Demissie DB
    Knowledge, practice of cervical cancer screening and associated factors among women police members of Addis Ababa police commission Ethiopia.
    BMC Cancer. 2023;23:961.
    PubMed     Abstract available
    
    
    
34. WANG J, Huang J, Ding H, Ma J, et al
    Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
    BMC Cancer. 2023;23:929.
    PubMed     Abstract available
    
    
    September 2023
35. SHAN M, Deng Y, Zou W, Fan S, et al
    Salvage radiotherapy strategy and its prognostic significance for patients with locoregional recurrent cervical cancer after radical hysterectomy: a multicenter retrospective 10-year analysis.
    BMC Cancer. 2023;23:905.
    PubMed     Abstract available
    
    
    
36. HE C, Pei C, Ma J
    Developing an evaluation indicators of health literacy for cervical cancer among Chinese women: a modified Delphi method study.
    BMC Cancer. 2023;23:863.
    PubMed     Abstract available
    
    
    
37. WANG F, Song S, Guo B, Li Y, et al
    Increased TCP11 gene expression can inhibit the proliferation, migration and promote apoptosis of cervical cancer cells.
    BMC Cancer. 2023;23:853.
    PubMed     Abstract available
    
    
    
38. ZHU M, Li X, Feng Y, Jia T, et al
    Impact of CD40 gene polymorphisms on the risk of cervical squamous cell carcinoma: a case-control study.
    BMC Cancer. 2023;23:845.
    PubMed     Abstract available
    
    
    
39. CHETTY-SEBASTIAN D, Assounga AG
    Regulatory T cell frequency in peripheral blood of women with advanced cervical Cancer including women living with HIV.
    BMC Cancer. 2023;23:830.
    PubMed     Abstract available
    
    
    
40. O'DOWD EL, Merriel SWD, Cheng VWT, Khan S, et al
    Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review.
    BMC Cancer. 2023;23:820.
    PubMed     Abstract available
    
    
    
41. ZAFAR S, Khan K, Badshah Y, Shahid K, et al
    Exploring the prognostic significance of PKCepsilon variants in cervical cancer.
    BMC Cancer. 2023;23:819.
    PubMed     Abstract available
    
    
    August 2023
42. SAMADI M, Mokhtari-Azad T, Nejati A, Norooz-Babaei Z, et al
    The antitumor effect of oncolytic respiratory syncytial virus via the tumor necrosis factor-alpha induction and ROS-bax-mediated mechanisms.
    BMC Cancer. 2023;23:803.
    PubMed     Abstract available
    
    
    
43. DADIPOOR S, Alavi A, Kader Z, Mohseni S, et al
    Predictive power of PEN-3 cultural model in cervical cancer screening among women: a cross- sectional study in South of Iran.
    BMC Cancer. 2023;23:730.
    PubMed     Abstract available
    
    
    July 2023
44. ZHANG C, Gu L, Xiao J, Jin F, et al
    Knockdown of RBM15 inhibits tumor progression and the JAK-STAT signaling pathway in cervical cancer.
    BMC Cancer. 2023;23:684.
    PubMed     Abstract available
    
    
    
45. MUSA J, Maiga M, Green SJ, Magaji FA, et al
    Vaginal microbiome community state types and high-risk human papillomaviruses in cervical precancer and cancer in North-central Nigeria.
    BMC Cancer. 2023;23:683.
    PubMed     Abstract available
    
    
    
46. MARTINEZ-GUTIERREZ J, Chima S, Boyd L, Sherwani A, et al
    Failure to follow up abnormal test results associated with cervical cancer in primary and ambulatory care: a systematic review.
    BMC Cancer. 2023;23:653.
    PubMed     Abstract available
    
    
    
47. NAJJEMBA JI, Ndagire R, Mulamira P, Kibudde S, et al
    Treatment compliance among adult cervical cancer patients receiving care at Uganda cancer institute, Uganda: a retrospective data review.
    BMC Cancer. 2023;23:631.
    PubMed     Abstract available
    
    
    June 2023
48. PENG H, Zhang J, Xu N, Zhou Y, et al
    Fan beam CT-guided online adaptive external radiotherapy of uterine cervical cancer: a dosimetric evaluation.
    BMC Cancer. 2023;23:588.
    PubMed     Abstract available
    
    
    May 2023
49. WU J, Guo Q, Zhu J, Wu Y, et al
    Developing a nomogram for preoperative prediction of cervical cancer lymph node metastasis by multiplex immunofluorescence.
    BMC Cancer. 2023;23:485.
    PubMed     Abstract available
    
    
    
50. JIANG Y, Wang J, Jiang P, Wang X, et al
    Clinical research of the value of high-risk CTV setting on intensity-modulated radiotherapy for stage IIB-IVA cervical cancer.
    BMC Cancer. 2023;23:481.
    PubMed     Abstract available
    
    
    
51. BELAY AS, Asmare WN, Kassie A
    Cervical cancer screening utilization and its predictors among women in bench Sheko Zone, Southwest Ethiopia: using health belief model.
    BMC Cancer. 2023;23:472.
    PubMed     Abstract available
    
    
    
52. LEONG E, Ong SK, Si-Ramlee KA, Naing L, et al
    Cancer incidence and mortality in Brunei Darussalam, 2011 to 2020.
    BMC Cancer. 2023;23:466.
    PubMed     Abstract available
    
    
    
53. MATOVU JK, Wagner GJ, Juncker M, Namisango E, et al
    Mediators and moderators of the effect of the game changers for cervical cancer prevention intervention on cervical cancer screening among previously unscreened social network members in Uganda.
    BMC Cancer. 2023;23:428.
    PubMed     Abstract available
    
    
    
54. YE Y, Li Z, Kang S, Yang Y, et al
    Treatment of FIGO 2018 stage IIIC cervical cancer with different local tumor factors.
    BMC Cancer. 2023;23:421.
    PubMed     Abstract available
    
    
    
55. BOOTH BB, Tranberg M, Gustafson LW, Christiansen AG, et al
    Risk of cervical intraepithelial neoplasia grade 2 or worse in women aged >/= 69 referred to colposcopy due to an HPV-positive screening test.
    BMC Cancer. 2023;23:405.
    PubMed     Abstract available
    
    
    April 2023
56. ZHANG HW, Zhong XM, Zhang ZH, Pang HW, et al
    Dose prediction of organs at risk in patients with cervical cancer receiving brachytherapy using needle insertion based on a neural network method.
    BMC Cancer. 2023;23:385.
    PubMed     Abstract available
    
    
    
57. GAN Q, Huang X, Zhao W, Liu H, et al
    AC010883.5 promotes cell proliferation, invasion, migration, and epithelial-to-mesenchymal transition in cervical cancer by modulating the MAPK signaling pathway.
    BMC Cancer. 2023;23:364.
    PubMed     Abstract available
    
    
    
58. RAHIMI M, Akbari A, Asadi F, Emami H, et al
    Cervical cancer survival prediction by machine learning algorithms: a systematic review.
    BMC Cancer. 2023;23:341.
    PubMed     Abstract available
    
    
    March 2023
59. ZHANG H, Wang X, Li Y, Bai Y, et al
    The hsa_circ_0000276-ceRNA regulatory network and immune infiltration in cervical cancer.
    BMC Cancer. 2023;23:222.
    PubMed     Abstract available
    
    
    February 2023
60. QIN D, Bai A, Xue P, Seery S, et al
    Colposcopic accuracy in diagnosing squamous intraepithelial lesions: a systematic review and meta-analysis of the International Federation of Cervical Pathology and Colposcopy 2011 terminology.
    BMC Cancer. 2023;23:187.
    PubMed     Abstract available
    
    
    
61. SHI L, Yang X, He L, Zheng C, et al
    Promoter hypermethylation analysis of host genes in cervical intraepithelial neoplasia and cervical cancers on histological cervical specimens.
    BMC Cancer. 2023;23:168.
    PubMed     Abstract available
    
    
    
62. XUE P, Seery S, Wang S, Jiang Y, et al
    Developing a predictive nomogram for colposcopists: a retrospective, multicenter study of cervical precancer identification in China.
    BMC Cancer. 2023;23:163.
    PubMed     Abstract available
    
    
    January 2023
63. LONG H, Li Y, Wang H, Guo B, et al
    C/EBPbeta expression decreases in cervical cancer and leads to tumorigenesis.
    BMC Cancer. 2023;23:79.
    PubMed     Abstract available
    
    
    
64. LI J, Li Y, Wang H, Shen L, et al
    Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer.
    BMC Cancer. 2023;23:51.
    PubMed     Abstract available
    
    
    December 2022
65. ZHANG GY, Zhang R, Bai P, Li SM, et al
    Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study.
    BMC Cancer. 2022;22:1331.
    PubMed     Abstract available
    
    
    
66. ASSEFA T, Arefaynie M, Mebratu W, Mohammed A, et al
    Determinants of cervical cancer screening utilization among women attending health facilities of Dessie town, Northeast Ethiopia.
    BMC Cancer. 2022;22:1330.
    PubMed     Abstract available
    
    
    
67. KUGUYO O, Chambwe N, Nhachi CFB, Tsikai N, et al
    A cervical cancer biorepository for pharmacogenomics research in Zimbabwe.
    BMC Cancer. 2022;22:1320.
    PubMed     Abstract available
    
    
    
68. SIRAIT LMF, Hamajima N, Suzuki Y, Wahyuningsih ES, et al
    Factors associated with positive cancer screening for the uterine cervix and breast in Jakarta Province, Indonesia: a cross-sectional study.
    BMC Cancer. 2022;22:1309.
    PubMed     Abstract available
    
    
    
69. TERASHIMA T, Konishi H, Sato Y, Igarashi M, et al
    Impact of coronavirus disease 2019 on the number of newly diagnosed cancer patients and examinations and surgeries performed for cancer in Japan: a nationwide study.
    BMC Cancer. 2022;22:1303.
    PubMed     Abstract available
    
    
    
70. OSMANI V, Fett S, Tauscher M, Donnachie E, et al
    HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis.
    BMC Cancer. 2022;22:1293.
    PubMed     Abstract available
    
    
    
71. JING H, Xiuhong W, Ying Y, Xiyun C, et al
    Complications of radical hysterectomy with pelvic lymph node dissection for cervical cancer: a 10-year single-centre clinical observational study.
    BMC Cancer. 2022;22:1286.
    PubMed     Abstract available
    
    
    
72. SEN S, Khan PK, Wadasadawala T, Mohanty SK, et al
    Socio-economic and regional variation in breast and cervical cancer screening among Indian women of reproductive age: a study from National Family Health Survey, 2019-21.
    BMC Cancer. 2022;22:1279.
    PubMed     Abstract available
    
    
    
73. HU Y, Han Y, Shen Y, Chen J, et al
    Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial.
    BMC Cancer. 2022;22:1270.
    PubMed     Abstract available
    
    
    November 2022
74. SEYRAFI N, Homayuni A, Hosseini Z, Aghamolaei T, et al
    Effectiveness of educational intervention on women's participation to cervical cancer screening: a quasi-experimental study based on PEN-3 model.
    BMC Cancer. 2022;22:1226.
    PubMed     Abstract available
    
    
    
75. TAKAMIZAWA S, Yazaki S, Kojima Y, Yoshida H, et al
    High mesothelin expression is correlated with non-squamous cell histology and poor survival in cervical cancer: a retrospective study.
    BMC Cancer. 2022;22:1215.
    PubMed     Abstract available
    
    
    
76. LI Y, Jia M, Cao L, Yu J, et al
    Silva cumulative score and its relationship with prognosis in Endocervical adenocarcinoma.
    BMC Cancer. 2022;22:1172.
    PubMed     Abstract available
    
    
    
77. QIN X, Wang C, Gong G, Wang L, et al
    Functional MRI radiomics-based assessment of pelvic bone marrow changes after concurrent chemoradiotherapy for cervical cancer.
    BMC Cancer. 2022;22:1149.
    PubMed     Abstract available
    
    
    
78. DU Y, Geng G, Zhao C, Gao T, et al
    LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21/PTEN axis.
    BMC Cancer. 2022;22:1145.
    PubMed     Abstract available
    
    
    October 2022
79. MPACHIKA-MFIPA F, Kululanga LI, Kazembe A, Mfipa D, et al
    Socio-demographic determinants of cervical cancer screening uptake among women of child-bearing age in Mangochi, Malawi: a facility-based cross-sectional study.
    BMC Cancer. 2022;22:1096.
    PubMed     Abstract available
    
    
    
80. VIKRAMDEO KS, Anand S, Pierce JY, Singh AP, et al
    Distribution of microbiota in cervical preneoplasia of racially disparate populations.
    BMC Cancer. 2022;22:1074.
    PubMed     Abstract available
    
    
    
81. BRUNO MT, Cassaro N, Mazza G, Guaita A, et al
    Spontaneous regression of cervical intraepithelial neoplasia 3 in women with a biopsy-cone interval of greater than 11 weeks.
    BMC Cancer. 2022;22:1072.
    PubMed     Abstract available
    
    
    
82. ZHANG J, Dong D, Wei Q, Ren L, et al
    CXCL10 serves as a potential serum biomarker complementing SCC-Ag for diagnosing cervical squamous cell carcinoma.
    BMC Cancer. 2022;22:1052.
    PubMed     Abstract available
    
    
    
83. CHEN H, Gu L, Zhang M, Chen H, et al
    Interaction of miR-200a-3p with YAP regulates cell proliferation and metastasis differentially in HPV-positive and HPV-negative cervical cancer cells.
    BMC Cancer. 2022;22:1039.
    PubMed     Abstract available
    
    
    September 2022
84. KARPINETS TV, Wu X, Solley T, El Alam MB, et al
    Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure.
    BMC Cancer. 2022;22:945.
    PubMed     Abstract available
    
    
    August 2022
85. DORJI N, Tshering S, Choden S, Chhetri M, et al
    Evaluation of the diagnostic performance of colposcopy in the diagnosis of histologic cervical intraepithelial neoplasia 2+ (CIN2+).
    BMC Cancer. 2022;22:930.
    PubMed     Abstract available
    
    
    
86. GLASMEYER L, Mcharo RD, Torres L, Lennemann T, et al
    Long-term follow-up on HIV infected and non-infected women with cervical cancer from Tanzania: staging, access to cancer-directed therapies and associated survival in a real-life remote setting.
    BMC Cancer. 2022;22:892.
    PubMed     Abstract available
    
    
    
87. LI M, Xiao Y, Liu M, Ning Q, et al
    MiR-26a-5p regulates proliferation, apoptosis, migration and invasion via inhibiting hydroxysteroid dehydrogenase like-2 in cervical cancer cell.
    BMC Cancer. 2022;22:876.
    PubMed     Abstract available
    
    
    
88. NASCIMENTO NPG, Gally TB, Borges GF, Campos LCG, et al
    Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis.
    BMC Cancer. 2022;22:862.
    PubMed     Abstract available
    
    
    
89. TIITI TA, Selabe SG, Bogers J, Lebelo RL, et al
    High prevalence of and factors associated with human papillomavirus infection among women attending a tertiary hospital in Gauteng Province, South Africa.
    BMC Cancer. 2022;22:854.
    PubMed     Abstract available
    
    
    July 2022
90. MARTINEZ A, Chantalat E, Angeles MA, Ferron G, et al
    Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer.
    BMC Cancer. 2022;22:810.
    PubMed     Abstract available
    
    
    
91. CHEN J, Li C, Cao Y, Zhu L, et al
    Toripalimab combined with concurrent platinum-based Chemoradiotherapy in patients with locally advanced cervical Cancer: an open-label, single-arm, phase II trial.
    BMC Cancer. 2022;22:793.
    PubMed     Abstract available
    
    
    
92. HE Z, Chen R, Hu S, Zhang Y, et al
    The value of HPV genotypes combined with clinical indicators in the classification of cervical squamous cell carcinoma and adenocarcinoma.
    BMC Cancer. 2022;22:776.
    PubMed     Abstract available
    
    
    
93. SINGH G, Sharma SK, Singh SK
    miR-34a negatively regulates cell cycle factor Cdt2/DTL in HPV infected cervical cancer cells.
    BMC Cancer. 2022;22:777.
    PubMed     Abstract available
    
    
    June 2022
94. MAN X, Yang X, Wei Z, Tan Y, et al
    High expression level of CXCL1/GROalpha is linked to advanced stage and worse survival in uterine cervical cancer and facilitates tumor cell malignant processes.
    BMC Cancer. 2022;22:712.
    PubMed     Abstract available
    
    
    
95. PAN B, Wan T, Jiang Y, Zheng X, et al
    Impact of the initial site of metastases on post-recurrence survival for neuroendocrine cervical cancer.
    BMC Cancer. 2022;22:655.
    PubMed     Abstract available
    
    
    
96. ZHANG W, Cao H, Yang J, Zhao J, et al
    The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer.
    BMC Cancer. 2022;22:636.
    PubMed     Abstract available
    
    
    
97. HWANG WY, Chang SJ, Kim HS, Kim NK, et al
    Gastrointestinal/genitourinary perforation and fistula formation with or without bevacizumab in patients with previously irradiated recurrent cervical cancer: a Korean multicenter retrospective study of the Gynecologic Oncology Research Investigators
    BMC Cancer. 2022;22:603.
    PubMed     Abstract available
    
    
    May 2022
98. CAO HZ, Yang WT, Zheng PS
    Cytotoxic effect of disulfiram/copper on human cervical cancer cell lines and LGR5-positive cancer stem-like cells.
    BMC Cancer. 2022;22:521.
    PubMed     Abstract available
    
    
    
99. JUDAH G, Dilib F, Darzi A, Huf S, et al
    A population survey on beliefs around cervical cancer screening: determining the barriers and facilitators associated with attendance.
    BMC Cancer. 2022;22:522.
    PubMed     Abstract available
    
    
    
100. CHEN R, Gan Q, Zhao S, Zhang D, et al
     DNA methylation of miR-138 regulates cell proliferation and EMT in cervical cancer by targeting EZH2.
     BMC Cancer. 2022;22:488.
     PubMed     Abstract available
     
     
     
101. BENIDER A, Bendahhou K, Sauvaget C, Mrabti H, et al
     Evolution of patterns of care for women with cervical cancer in Morocco over a decade.
     BMC Cancer. 2022;22:479.
     PubMed     Abstract available
     
     
     April 2022
102. HEMMINKI K, Kanerva A, Forsti A, Hemminki A, et al
     Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment.
     BMC Cancer. 2022;22:456.
     PubMed     Abstract available
     
     
     
103. LI K, Xu H, Wang S, Qin P, et al
     Disparities in the increases of cervical cancer incidence rates: observations from a city-wide population-based study.
     BMC Cancer. 2022;22:419.
     PubMed     Abstract available
     
     
     
104. HE Y, Han SB, Liu Y, Zhang JJ, et al
     Role of APOA1 in the resistance to platinum-based chemotherapy in squamous cervical cancer.
     BMC Cancer. 2022;22:411.
     PubMed     Abstract available
     
     
     
105. GALLARDO-ALVARADO L, Cantu-de Leon D, Ramirez-Morales R, Santiago-Concha G, et al
     Tumor histology is an independent prognostic factor in locally advanced cervical carcinoma: A retrospective study.
     BMC Cancer. 2022;22:401.
     PubMed     Abstract available
     
     
     
106. WEI B, Zhang B, Xue P, Seery S, et al
     Improving colposcopic accuracy for cervical precancer detection: a retrospective multicenter study in China.
     BMC Cancer. 2022;22:388.
     PubMed     Abstract available
     
     
     
107. WU X, Feng H, Gao S, Feng H, et al
     A multicenter noninferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stage IA1 with LVSI, IA2): study protocol of the LAUNCH 1 trial.
     BMC Cancer. 2022;22:384.
     PubMed     Abstract available
     
     
     
108. HOLMQVIST A, Lindahl G, Mikivier R, Uppungunduri S, et al
     Age as a potential predictor of acute side effects during chemoradiotherapy in primary cervical cancer patients.
     BMC Cancer. 2022;22:371.
     PubMed     Abstract available
     
     
     
109. CHEN L, Qing J, Xiao Y, Huang X, et al
     TIM-1 promotes proliferation and metastasis, and inhibits apoptosis, in cervical cancer through the PI3K/AKT/p53 pathway.
     BMC Cancer. 2022;22:370.
     PubMed     Abstract available
     
     
     
110. WANG H, Jiang Y, Liang Y, Wei L, et al
     Observation of the cervical microbiome in the progression of cervical intraepithelial neoplasia.
     BMC Cancer. 2022;22:362.
     PubMed     Abstract available
     
     
     March 2022
111. PARK SJ, Kong TW, Kim T, Lee M, et al
     Safety and efficacy study of laparoscopic or robotic radical surgery using an endoscopic stapler for inhibiting tumour spillage of cervical malignant neoplasms evaluating survival (SOLUTION): a multi-centre, open-label, single-arm, phase II trial prot
     BMC Cancer. 2022;22:331.
     PubMed     Abstract available
     
     
     
112. MKUU RS, Staras SA, Szurek SM, D'Ingeo D, et al
     Clinicians' perceptions of barriers to cervical cancer screening for women living with behavioral health conditions: a focus group study.
     BMC Cancer. 2022;22:252.
     PubMed     Abstract available
     
     
     February 2022
113. ZHANG H, Yu R, Zhang L, Wang R, et al
     Chemotherapy versus chemoradiotherapy for FIGO stages IB1 and IIA1 cervical squamous cancer patients with lymphovascular space invasion: a retrospective study.
     BMC Cancer. 2022;22:202.
     PubMed     Abstract available
     
     
     
114. LIU W, Jiang Q, Sun C, Liu S, et al
     Developing a 5-gene prognostic signature for cervical cancer by integrating mRNA and copy number variations.
     BMC Cancer. 2022;22:192.
     PubMed     Abstract available
     
     
     
115. BHAT A, Yadav J, Thakur K, Aggarwal N, et al
     Transcriptome analysis of cervical cancer exosomes and detection of HPVE6*I transcripts in exosomal RNA.
     BMC Cancer. 2022;22:164.
     PubMed     Abstract available
     
     
     
116. SINGH M, Jha RP, Shri N, Bhattacharyya K, et al
     Secular trends in incidence and mortality of cervical cancer in India and its states, 1990-2019: data from the Global Burden of Disease 2019 Study.
     BMC Cancer. 2022;22:149.
     PubMed     Abstract available
     
     
     
117. FISCHER S, Kuebler U, Abbruzzese E, Breymann C, et al
     Endogenous oestradiol and progesterone as predictors of oncogenic human papillomavirus (HPV) persistence.
     BMC Cancer. 2022;22:145.
     PubMed     Abstract available
     
     
     
118. METAXAS T, Kenfack B, Sormani J, Tincho E, et al
     Acceptability and safety of thermal ablation to prevent cervical cancer in sub-Saharan Africa.
     BMC Cancer. 2022;22:132.
     PubMed     Abstract available
     
     
     January 2022
119. REN J, Li L, Yu B, Xu E, et al
     Extracellular vesicles mediated proinflammatory macrophage phenotype induced by radiotherapy in cervical cancer.
     BMC Cancer. 2022;22:88.
     PubMed     Abstract available
     
     
     
120. HOU M, Song K, Ren J, Wang K, et al
     Comparative analysis of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in evaluating the histological grade of cervical squamous carcinoma.
     BMC Cancer. 2022;22:87.
     PubMed     Abstract available
     
     
     
121. SONG F, Yan P, Huang X, Wang C, et al
     Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
     BMC Cancer. 2022;22:42.
     PubMed     Abstract available
     
     
     
122. JIANG AG, Cai X
     Construction and validation of the prognostic model for patients with neuroendocrine cervical carcinoma: a competing risk nomogram analysis.
     BMC Cancer. 2022;22:4.
     PubMed     Abstract available
     
     
     November 2021
123. DENG Q, Long Q, Liu Y, Yang Z, et al
     Prognostic value of preoperative peripheral blood mean platelet volume/platelet count ratio (MPV/PC) in patients with resectable cervical cancer.
     BMC Cancer. 2021;21:1282.
     PubMed     Abstract available
     
     
     
124. KIM SI, Kim JY, Wee CW, Lee M, et al
     Survival impact of additional chemotherapy after adjuvant concurrent chemoradiation in patients with early cervical cancer who underwent radical hysterectomy.
     BMC Cancer. 2021;21:1260.
     PubMed     Abstract available
     
     
     
125. CHEN L, Lin L, Li L, Xie Z, et al
     Lymphatic leakage after pelvic lymphadenectomy for cervical cancer: a retrospective case-control study.
     BMC Cancer. 2021;21:1242.
     PubMed     Abstract available
     
     
     
126. YANG P, Ruan Y, Yan Z, Gao Y, et al
     Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.
     BMC Cancer. 2021;21:1230.
     PubMed     Abstract available
     
     
     October 2021
127. ZHAO M, Pu X, Yan YJ, Zhang S, et al
     The quality of life in women with cervical cancer and precancerous lesions of Han and ethnic minorities in Southwest China.
     BMC Cancer. 2021;21:1110.
     PubMed     Abstract available
     
     
     
128. DERESSA BT, Assefa M, Tafesse E, Kantelhardt EJ, et al
     Contemporary treatment patterns and survival of cervical cancer patients in Ethiopia.
     BMC Cancer. 2021;21:1102.
     PubMed     Abstract available
     
     
     
129. CHEN L, Niu Y, Wan X, Yu L, et al
     Clinicopathological features and outcomes in gastric-type of HPV-independent endocervical adenocarcinomas.
     BMC Cancer. 2021;21:1095.
     PubMed     Abstract available
     
     
     
130. CHEN C, Duan H, Zhang W, Zhao H, et al
     Comparison of survival outcomes with or without Para-aortic lymphadenectomy in surgical patients with stage IB1-IIA2 cervical cancer in China from 2004 to 2016.
     BMC Cancer. 2021;21:1091.
     PubMed     Abstract available
     
     
     
131. SIMSONE Z, Freivalds T, Bema D, Mikelsone I, et al
     Cancer microcell initiation and determination.
     BMC Cancer. 2021;21:1087.
     PubMed     Abstract available
     
     
     
132. CHENG J, Liu B, Wang B, Long X, et al
     Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis.
     BMC Cancer. 2021;21:1078.
     PubMed     Abstract available
     
     
     September 2021
133. COQUAN E, Brachet PE, Licaj I, Leconte A, et al
     CABOCOL-01 trial: a single-arm phase II study assessing safety and efficacy of Cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure.
     BMC Cancer. 2021;21:1054.
     PubMed     Abstract available
     
     
     
134. KAWAMURA M, Koide Y, Murai T, Ishihara S, et al
     The importance of choosing the right strategy to treat small cell carcinoma of the cervix: a comparative analysis of treatments.
     BMC Cancer. 2021;21:1046.
     PubMed     Abstract available
     
     
     
135. DESTAW A, Midaksa M, Addissie A, Kantelhardt EJ, et al
     Cervical cancer screening "see and treat approach": real-life uptake after invitation and associated factors at health facilities in Gondar, Northwest Ethiopia.
     BMC Cancer. 2021;21:1031.
     PubMed     Abstract available
     
     
     
136. YANG J, Yan Z, Wang Y, Xu J, et al
     Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer.
     BMC Cancer. 2021;21:997.
     PubMed     Abstract available
     
     
     August 2021
137. LIU J, Liu X, Guo Z, Lv X, et al
     Ultrasound-guided fine needle aspiration cytology of Para-aortic lymph node metastasis in uterine cervical cancer: diagnostic accuracy and impact on clinical decision making.
     BMC Cancer. 2021;21:964.
     PubMed     Abstract available
     
     
     
138. BONI SP, Gnahatin F, Comoe JC, Tchounga B, et al
     Barriers and facilitators in cervical cancer screening uptake in Abidjan, Cote d'Ivoire in 2018: a cross-sectional study.
     BMC Cancer. 2021;21:952.
     PubMed     Abstract available
     
     
     
139. ZHONG G, Wang Y, Xie Q, Lin R, et al
     HPV-specific risk assessment of cervical cytological abnormalities.
     BMC Cancer. 2021;21:949.
     PubMed     Abstract available
     
     
     
140. HANSEN BT, Campbell S, Nygard M
     Regional differences in cervical cancer incidence and associated risk behaviors among Norwegian women: a population-based study.
     BMC Cancer. 2021;21:935.
     PubMed     Abstract available
     
     
     
141. WU B, Xi S
     Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
     BMC Cancer. 2021;21:928.
     PubMed     Abstract available
     
     
     July 2021
142. KIM JY, Lee DW, Kim MJ, Shin JE, et al
     Secondhand smoke exposure, diabetes, and high BMI are risk factors for uterine cervical cancer: a cross-sectional study from the Korea national health and nutrition examination survey (2010-2018).
     BMC Cancer. 2021;21:880.
     PubMed     Abstract available
     
     
     
143. LI X, Xu C, Yu Y, Guo Y, et al
     Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma.
     BMC Cancer. 2021;21:866.
     PubMed     Abstract available
     
     
     
144. QI J, Zhou L, Li D, Yang J, et al
     Oncogenic role of ALX3 in cervical cancer cells through KDM2B-mediated histone demethylation of CDC25A.
     BMC Cancer. 2021;21:819.
     PubMed     Abstract available
     
     
     
145. MARTINS J, Vaz AF, Grion RC, Costa-Paiva L, et al
     Correction to: Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.
     BMC Cancer. 2021;21:811.
     PubMed    
     
     
     
146. LI Y, Luo H, Zhang X, Chang J, et al
     Development and validation of a clinical prediction model for endocervical curettage decision-making in cervical lesions.
     BMC Cancer. 2021;21:804.
     PubMed     Abstract available
     
     
     
147. DAI MZ, Qiu Y, Di XH, Shi WW, et al
     Association of cervical carcinogenesis risk with HPV16 E6 and E7 variants in the Taizhou area, China.
     BMC Cancer. 2021;21:769.
     PubMed     Abstract available
     
     
     June 2021
148. WU B, Xi S
     Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
     BMC Cancer. 2021;21:733.
     PubMed     Abstract available
     
     
     
149. JIANG P, Cao Y, Gao F, Sun W, et al
     SNX10 and PTGDS are associated with the progression and prognosis of cervical squamous cell carcinoma.
     BMC Cancer. 2021;21:694.
     PubMed     Abstract available
     
     
     
150. MARTINS J, Vaz AF, Grion RC, Costa-Paiva L, et al
     Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.
     BMC Cancer. 2021;21:682.
     PubMed     Abstract available
     
     
     
151. ZHAO J, Cao H, Zhang W, Fan Y, et al
     SOX14 hypermethylation as a tumour biomarker in cervical cancer.
     BMC Cancer. 2021;21:675.
     PubMed     Abstract available
     
     
     
152. RAKHSHANDA S, Dalal K, Chowdhury HA, Mayaboti CA, et al
     Assessing service availability and readiness to manage cervical cancer in Bangladesh.
     BMC Cancer. 2021;21:670.
     PubMed     Abstract available
     
     
     
153. AKHAVAN S, Alibakhshi A, Parsapoor M, Alipour A, et al
     Comparison of therapeutic effects of chemo-radiotherapy with neoadjuvant chemotherapy before radical surgery in patients with bulky cervical carcinoma (stage IB3 & IIA2).
     BMC Cancer. 2021;21:667.
     PubMed     Abstract available
     
     
     
154. ZOU D, Guo M, Zhou Q
     A clinical study of pegylated recombinant human granulocyte colony stimulating factor (PEG-rhG-CSF) in preventing neutropenia during concurrent chemoradiotherapy of cervical cancer.
     BMC Cancer. 2021;21:661.
     PubMed     Abstract available
     
     
     May 2021
155. DENG ZM, Dai FF, Zhou Q, Cheng YX, et al
     Hsa_circ_0000301 facilitates the progression of cervical cancer by targeting miR-1228-3p/IRF4 Axis.
     BMC Cancer. 2021;21:583.
     PubMed     Abstract available
     
     
     
156. CHEN HH, Meng WY, Li RZ, Wang QY, et al
     Potential prognostic factors in progression-free survival for patients with cervical cancer.
     BMC Cancer. 2021;21:531.
     PubMed     Abstract available
     
     
     
157. LI W, Xiong L, Zhu Q, Lu H, et al
     Assessment of retroperitoneal lymph node status in locally advanced cervical cancer.
     BMC Cancer. 2021;21:484.
     PubMed     Abstract available
     
     
     April 2021
158. FENG Y, Wang Y, Xie Y, Wu S, et al
     Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
     BMC Cancer. 2021;21:450.
     PubMed     Abstract available
     
     
     
159. LEE F, Bula A, Chapola J, Mapanje C, et al
     Women's experiences in a community-based screen-and-treat cervical cancer prevention program in rural Malawi: a qualitative study.
     BMC Cancer. 2021;21:428.
     PubMed     Abstract available
     
     
     
160. LI Y, Chen Z, Wang X, Li X, et al
     Clinical outcomes observation in stage IIB-IIIB cervical cancer treated by adjuvant surgery following concurrent chemoradiotherapy.
     BMC Cancer. 2021;21:442.
     PubMed     Abstract available
     
     
     
161. LIU H, Ye X, Li D, Yao Q, et al
     Incidence, clinical risk and prognostic factors for liver metastasis in patients with cervical cancer: a population-based retrospective study.
     BMC Cancer. 2021;21:421.
     PubMed     Abstract available
     
     
     
162. MA D, Pan Z, Chang Q, Zhang JJ, et al
     KLF5-mediated Eppk1 expression promotes cell proliferation in cervical cancer via the p38 signaling pathway.
     BMC Cancer. 2021;21:377.
     PubMed     Abstract available
     
     
     
163. TISLER A, Ojavee SE, Veerus P, Soodla P, et al
     Cervical cancer screening patterns among HIV-positive women in Estonia: a population-based retrospective cohort study.
     BMC Cancer. 2021;21:350.
     PubMed     Abstract available
     
     
     March 2021
164. ZHANG SW, Luo RZ, Sun XY, Yang X, et al
     Co-expression of SOX2 and HR-HPV RISH predicts poor prognosis in small cell neuroendocrine carcinoma of the uterine cervix.
     BMC Cancer. 2021;21:332.
     PubMed     Abstract available
     
     
     
165. SHARMIN S, Zohura FT, Islam MS, Shimonty A, et al
     Mutational profiles of marker genes of cervical carcinoma in Bangladeshi patients.
     BMC Cancer. 2021;21:289.
     PubMed     Abstract available
     
     
     
166. GAETE S, Auguste A, Bhakkan B, Peruvien J, et al
     Frequent high-risk HPV co-infections excluding types 16 or 18 in cervical neoplasia in Guadeloupe.
     BMC Cancer. 2021;21:281.
     PubMed     Abstract available
     
     
     
167. SATO A, Matsubayashi K, Morishima T, Nakata K, et al
     Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: a population-based study.
     BMC Cancer. 2021;21:264.
     PubMed     Abstract available
     
     
     
168. JU Z, Guo W, Gu S, Zhou J, et al
     CT based automatic clinical target volume delineation using a dense-fully connected convolution network for cervical Cancer radiation therapy.
     BMC Cancer. 2021;21:243.
     PubMed     Abstract available
     
     
     
169. ARARSA T, Tadele N, Ayalew Y, Gela D, et al
     Knowledge towards cervical cancer screening and associated factors among urban health extension workers at Addis Ababa, Ethiopia: facility based cross-sectional survey.
     BMC Cancer. 2021;21:224.
     PubMed     Abstract available
     
     
     February 2021
170. YANG E, Huang S, Ran X, Huang Y, et al
     The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center.
     BMC Cancer. 2021;21:203.
     PubMed     Abstract available
     
     
     
171. CHU G, Liu X, Yu W, Chen M, et al
     Cisplatin plus paclitaxel chemotherapy with or without bevacizumab in postmenopausal women with previously untreated advanced cervical cancer: a retrospective study.
     BMC Cancer. 2021;21:133.
     PubMed     Abstract available
     
     
     
172. GOUY S, Seebacher V, Chargari C, Terroir M, et al
     False negative rate at (18)F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technology.
     BMC Cancer. 2021;21:135.
     PubMed     Abstract available
     
     
     
173. OBOL JH, Lin S, Obwolo MJ, Harrison R, et al
     Knowledge, attitudes, and practice of cervical cancer prevention among health workers in rural health centres of Northern Uganda.
     BMC Cancer. 2021;21:110.
     PubMed     Abstract available
     
     
     
174. CHI RA, van der Watt P, Wei W, Birrer MJ, et al
     Inhibition of Kpnbeta1 mediated nuclear import enhances cisplatin chemosensitivity in cervical cancer.
     BMC Cancer. 2021;21:106.
     PubMed     Abstract available
     
     
     January 2021
175. DEL MORAL-HERNANDEZ O, Hernandez-Sotelo D, Alarcon-Romero LDC, Mendoza-Catalan MA, et al
     TOP2A/MCM2, p16(INK4a), and cyclin E1 expression in liquid-based cytology: a biomarkers panel for progression risk of cervical premalignant lesions.
     BMC Cancer. 2021;21:39.
     PubMed     Abstract available
     
     
     December 2020
176. BAO H, Wang L, Brown M, Zhang M, et al
     A nationally quasi-experimental study to assess the impact of partial organized breast and cervical cancer screening programme on participation and inequalities.
     BMC Cancer. 2020;20:1191.
     PubMed     Abstract available
     
     
     November 2020
177. TAKEKUMA M, Takahashi F, Mabuchi S, Kudaka W, et al
     Propensity score-matched analysis of systemic chemotherapy versus salvage hysterectomy for persistent cervical cancer after definitive radiotherapy/concurrent chemoradiotherapy.
     BMC Cancer. 2020;20:1169.
     PubMed     Abstract available
     
     
     
178. CAI L, Hu C, Yu S, Liu L, et al
     Identification and validation of a six-gene signature associated with glycolysis to predict the prognosis of patients with cervical cancer.
     BMC Cancer. 2020;20:1133.
     PubMed     Abstract available
     
     
     
179. PITTALIS C, Panteli E, Schouten E, Magongwa I, et al
     Breast and cervical cancer screening services in Malawi: a systematic review.
     BMC Cancer. 2020;20:1101.
     PubMed     Abstract available
     
     
     
180. HERNANDEZ VARGAS JA, Ramirez Barbosa PX, Gil Quijano AM, Valbuena AM, et al
     Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: an administrative registry data analysis.
     BMC Cancer. 2020;20:1097.
     PubMed     Abstract available
     
     
     
181. BANU N, Riera-Leal A, Haramati J, Ortiz-Lazareno PC, et al
     B7-H6, an immunoligand for the natural killer cell activating receptor NKp30, reveals inhibitory effects on cell proliferation and migration, but not apoptosis, in cervical cancer derived-cell lines.
     BMC Cancer. 2020;20:1083.
     PubMed     Abstract available
     
     
     October 2020
182. LIU J, Li Y, Chen X, Xu X, et al
     Upregulation of miR-205 induces CHN1 expression, which is associated with the aggressive behaviour of cervical cancer cells and correlated with lymph node metastasis.
     BMC Cancer. 2020;20:1029.
     PubMed     Abstract available
     
     
     September 2020
183. GESINK MP, Chamberlain RM, Mwaiselage J, Kahesa C, et al
     Quantifying the under-estimation of cervical Cancer in remote regions of Tanzania.
     BMC Cancer. 2020;20:939.
     PubMed     Abstract available
     
     
     
184. CHEN M, Wang H, Liang Y, Hu M, et al
     Establishment of multifactor predictive models for the occurrence and progression of cervical intraepithelial neoplasia.
     BMC Cancer. 2020;20:926.
     PubMed     Abstract available
     
     
     
185. CHEN S, Li K
     HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer.
     BMC Cancer. 2020;20:924.
     PubMed     Abstract available
     
     
     July 2020
186. TESFAW G, Ahmed Y, Gedefaw L, Dube L, et al
     Liquid-based cytology for the detection of cervical intraepithelial lesions in Jimma town, Ethiopia.
     BMC Cancer. 2020;20:706.
     PubMed     Abstract available
     
     
     
187. LEE SY, Chae DK, Lee SH, Lim Y, et al
     Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.
     BMC Cancer. 2020;20:694.
     PubMed     Abstract available
     
     
     
188. AARNIO R, Ostensson E, Olovsson M, Gustavsson I, et al
     Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.
     BMC Cancer. 2020;20:645.
     PubMed     Abstract available
     
     
     June 2020
189. KNAUL FM, Doubova SV, Gonzalez Robledo MC, Durstine A, et al
     Self-identity, lived experiences, and challenges of breast, cervical, and prostate cancer survivorship in Mexico: a qualitative study.
     BMC Cancer. 2020;20:577.
     PubMed     Abstract available
     
     
     
190. ITO M, Kodaira T, Koide Y, Okuda T, et al
     Role of high-dose salvage radiotherapy for oligometastases of the localised abdominal/pelvic lymph nodes: a retrospective study.
     BMC Cancer. 2020;20:540.
     PubMed     Abstract available
     
     
     
191. VAN DE LAAR RLO, Hofhuis W, Duijnhoven RG, Polinder S, et al
     Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial.
     BMC Cancer. 2020;20:539.
     PubMed     Abstract available
     
     
     May 2020
192. BRUNO MT, Scalia G, Cassaro N, Boemi S, et al
     Multiple HPV 16 infection with two strains: a possible marker of neoplastic progression.
     BMC Cancer. 2020;20:444.
     PubMed     Abstract available
     
     
     
193. ZHANG J, Zhang D, Yang Z, Wang X, et al
     The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China.
     BMC Cancer. 2020;20:443.
     PubMed     Abstract available
     
     
     
194. GUO HT, Bi XH, Lei T, Lv X, et al
     Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors.
     BMC Cancer. 2020;20:441.
     PubMed     Abstract available
     
     
     
195. CHEN P, Jiao L, Ren F, Wang DB, et al
     Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma.
     BMC Cancer. 2020;20:423.
     PubMed     Abstract available
     
     
     
196. EJEGOD DM, Lagheden C, Bhatia R, Pedersen H, et al
     Clinical validation of full genotyping CLART(R) HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening.
     BMC Cancer. 2020;20:396.
     PubMed     Abstract available
     
     
     April 2020
197. SILVA NNT, Santos ACS, Nogueira VM, Carneiro CM, et al
     3'UTR polymorphism of Thymidylate Synthase gene increased the risk of persistence of pre-neoplastic cervical lesions.
     BMC Cancer. 2020;20:323.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.